GastroenterologyNews.net

Gastroenterology Xagena

Xagena Mappa
Medical Meeting
Xagena Salute
Cardiobase

The incidence and short-term outcome of anaemia in inflammatory bowel disease ( IBD ) are largely unknown. A study has attempted to determine the incidence, prevalence and clinical outcome of anae ...


Inflammatory bowel disease [ IBD ] is associated with a 1.5- to 3-fold increased risk of venous thromboembolism [ VTE ] events. Researchers have determined the risk of venous thromboembolism in in ...


Tofacitinib ( Xeljanz ) is an oral, small molecule Janus kinase [ JAK ] inhibitor that is being investigated for ulcerative colitis [ UC ]. Researchers have evaluated health-related quality of life ...


Population-based prospective cohort studies investigating fibre intake and development of inflammatory bowel disease are lacking. Researchers have investigated the association between fibre intake ...


In phase 3 studies of Ustekinumab ( Stelara ), a fully human monoclonal IL-12/23p40 antibody approved for moderate-to-severe Crohn's disease, patients entered a long-term extension after completing 8 ...


In pediatric Crohn's disease, fat mass improves over time with treatment, but lean mass deficits persist. This observational study of the associations of physical activity and dietary intake wi ...


Vitamin and iron deficiencies are common in patients with inflammatory bowel disease ( IBD ) as a result of chronic intestinal inflammation, increase in demand, or dietary restrictions. Researcher ...


The U.S. Food and Drug Administration ( FDA ) has approved Keytruda ( Pembrolizumab ), an anti-PD-1 therapy, for the treatment of patients with recurrent locally advanced or metastatic gastric or gast ...


Agents that induce an immune response against tumors by altering T-cell regulation have increased survival times of patients with advanced-stage tumors, such as melanoma or lung cancer. Researcher ...


Researchers have found early evidence that a common but harmless virus could be behind the celiac disease, by causing the immune system to turn against gluten. Up until now, research has mainly foc ...


Vedolizumab ( Entyvio ) is a gut-selective antibody to alpha4beta7 integrin for the treatment of ulcerative colitis and Crohn's disease. An integrated summary of the safety of Vedolizumab was reported ...


Data from a randomized, double-blind, multicenter, exploratory phase 1b study evaluating the effects of investigational oral GED-0301 ( Mongersen ) 160 mg on both endoscopic response and clinical remi ...


Interim topline data from a randomized, double-blind, multicenter, exploratory phase 1b study evaluating the effects of oral Mongersen ( GED-0301 ) on both endoscopic and clinical outcomes in patients ...


Clostridium difficile infection ( CDI ) is the leading cause of antibiotic-associated diarrhea. Clostridium difficile infection has increased in incidence and severity over the past decade, and is a g ...


Recurrent Clostridium difficile infection ( rCDI ) contributes to a significant burden of disease in patients with inflammatory bowel disease ( IBD ). In the RECIDIVISM study, researchers have sough ...